Gentian Diagnostics Feed

2026-03-20 08:36:58 Gentian Diagnostics: Annual report 2025 38,00 NOK | -1,81% | 0,09 MNOK

2026-03-12 10:36:18 Gentian Diagnostics ASA - Mandatory notification of subscription of shares by primary insiders in Employee Share Purchase Program 39,10 NOK | +2,89% | 0,80 MNOK

2026-03-12 10:36:08 Gentian Diagnostics ASA - Employee Share Purchase Program and share capital increase 39,10 NOK | +2,89% | 0,80 MNOK

2026-02-19 10:21:08 GENT: Mandatory notification of trade 44,90 NOK | +12,25% | 5,45 MNOK

2026-02-13 09:26:47 GENT: Mandatory notification of trade 38,00 NOK | -3,06% | 4,80 MNOK

2026-02-12 16:09:05 GENT: Mandatory notification of trade 39,20 NOK | -27,41% | 10,7 MNOK

2026-02-12 09:49:35 Gentian Diagnostics: Key information relating to the proposed cash dividend 39,20 NOK | -27,41% | 10,7 MNOK

2026-02-11 08:23:12 GENT: Update on the development of the NT-proBNP assay 54,00 NOK | -6,90% | 1,10 MNOK

2026-02-11 08:19:52 Gentian Diagnostics: Fourth quarter 2025 report 54,00 NOK | -6,90% | 1,10 MNOK

2026-02-04 08:22:46 Gentian Diagnostics: Invitation to presentation of fourth quarter results 57,00 NOK | 0,00% | 0,78 MNOK

2026-01-28 14:38:59 GENT: Gentian Diagnostics invites to NT-proBNP educational webinar 58,00 NOK | -0,34% | 3,65 MNOK

2026-01-07 10:04:12 GENT: Gentian Diagnostics announces exclusive partnership for the development of a novel diagnostic assay with a leading global IVD company 57,20 NOK | 0,00% | 1,79 MNOK

2025-12-18 09:06:20 Gentian Diagnostics: Update on NT-proBNP 58,00 NOK | -0,34% | 0,23 MNOK

2025-11-25 08:10:05 GENT: Gentian Diagnostics presents at the DNB Nordic Healthcare Conference 53,40 NOK | -0,74% | 5,60 MNOK

2025-11-11 11:32:52 GENT: Financial calendar 54,60 NOK | -1,09% | 0,09 MNOK

2025-10-28 08:41:19 GENT: Mandatory notification of trade 56,80 NOK | +3,65% | 1,00 MNOK

2025-10-23 10:15:19 Gentian Diagnostics: Study Confirms the Value of Calprotectin in Early Detection of Neonatal Infections and Sepsis 53,20 NOK | -3,27% | 7,55 MNOK

2025-10-23 08:00:00 Gentian Diagnostics: Third quarter 2025 report 53,20 NOK | -3,27% | 7,55 MNOK

2025-10-16 09:55:37 Gentian Diagnostics: Invitation to presentation of third quarter results 54,40 NOK | -2,86% | 0,23 MNOK

2025-09-16 08:11:16 GENT: Gentian Diagnostics presents at the Pareto Securities Healthcare conference 55,00 NOK | +1,48% | 0,20 MNOK

2025-07-10 08:00:00 Gentian Diagnostics: Second quarter 2025 report 58,40 NOK | -7,89% | 2,20 MNOK

2025-07-03 13:22:20 Gentian Diagnostics: Invitation to presentation of second quarter results 62,80 NOK | -1,26% | 0,22 MNOK

2025-06-02 16:34:06 GENT: Flaggemelding Gentian Diagnostics ASA 60,20 NOK | -2,90% | 0,33 MNOK

2025-05-23 11:39:00 GENT: Disclosure of shareholding 57,00 NOK | +1,79% | 28,0 MNOK

2025-05-22 10:47:47 GENT: Disclosure of large shareholding 56,00 NOK | 0,00% | 2,77 MNOK

2025-05-08 10:00:54 GENT: Mandatory notification of trade 57,00 NOK | +6,34% | 7,14 MNOK

2025-05-07 08:07:46 Gentian Diagnostics: Ex dividend NOK 0.40 today 53,60 NOK | +8,06% | 4,59 MNOK

2025-05-07 08:00:00 Gentian Diagnostics: First quarter 2025 report 53,60 NOK | +8,06% | 4,59 MNOK

2025-05-06 12:14:58 Gentian Diagnostics: Minutes from Annual General Meeting 49,60 NOK | +0,40% | 0,01 MNOK

2025-04-30 10:10:46 Gentian Diagnostics: Invitation to presentation of first quarter results 47,00 NOK | -6,00% | 0,41 MNOK

2025-04-11 12:56:28 Gentian Diagnostics: Notice of annual general meeting 50,00 NOK | +9,17% | 0,15 MNOK

2025-04-07 14:23:03 GENT: Mandatory notification of trade 44,00 NOK | -5,17% | 0,89 MNOK

2025-03-28 10:30:07 GENT: Gentian Diagnostics strengthens commercial capabilities with key appointments 47,60 NOK | +5,78% | 0,10 MNOK

2025-03-21 14:58:02 Correction: Gentian Diagnostics: Annual report 2024 46,00 NOK | -5,35% | 0,10 MNOK

2025-03-21 08:35:28 Gentian Diagnostics: Annual report 2024 46,00 NOK | -5,35% | 0,10 MNOK

2025-03-19 08:47:41 GENT: Gentian Diagnostics Receives Notice of Allowance for NT-proBNP Assay Patent in Japan 48,00 NOK | -1,64% | 0,12 MNOK

2025-03-12 12:04:58 Gentian Diagnostics: Key information relating to the proposed cash dividend 46,40 NOK | -1,28% | 0,15 MNOK

2025-03-10 12:44:14 GENT: Gentian Diagnostics and Beckman Coulter Partner to Launch Gentian GCAL® Calprotectin Immunoassay 47,00 NOK | +0,43% | 0,48 MNOK

2025-03-03 10:29:57 GENT: Mandatory notification of trade 48,00 NOK | -2,83% | 0,53 MNOK

2025-03-03 10:26:23 GENT: Notification of trade 48,00 NOK | -2,83% | 0,53 MNOK

2025-03-03 10:12:25 GENT: Disclosure of large shareholding in Gentian Diagnotics ASA 48,00 NOK | -2,83% | 0,53 MNOK

2025-03-03 10:06:45 Disclosure of shareholdings - Holta Invest AS 48,00 NOK | -2,83% | 0,53 MNOK

2025-02-12 08:00:00 Gentian Diagnostics: Fourth quarter 2024 report 50,00 NOK | +2,46% | 1,11 MNOK

2025-02-05 08:30:06 Gentian Diagnostics: Invitation to presentation of fourth quarter results 46,20 NOK | +5,00% | 0,06 MNOK

2024-12-16 14:09:26 GENT: Mandatory notification of trade 39,20 NOK | +0,51% | 0,09 MNOK

2024-12-04 10:01:50 GENT: Financial calendar 40,00 NOK | +1,01% | 0,73 MNOK

2024-11-26 10:58:28 GENT: Gentian Diagnostics presents at the DNB Nordic Healthcare Conference 41,40 NOK | +3,50% | 0,17 MNOK

2024-10-31 08:00:00 Gentian Diagnostics: Third quarter 2024 report 43,60 NOK | -1,36% | 0,03 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Gentian Diagnostics

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden